Create
Log in
Enquire now
US Patent 11479812 Methods and compositions for determining ploidy
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Patent
Current Assignee
Natera
Date Filed
May 10, 2016
Date of Patent
October 25, 2022
Patent Applicant
Natera
Patent Application Number
15573800
Patent Citations
US Patent 10174369 Methods for non-invasive prenatal ploidy calling
US Patent 10017810 Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US Patent 10041127 Systems and methods to detect rare mutations and copy number variation
US Patent 10061890 Methods for non-invasive prenatal ploidy calling
US Patent 10081839 System and method for cleaning noisy genetic data and determining chromosome copy number
US Patent 10083273 System and method for cleaning noisy genetic data and determining chromosome copy number
US Patent 10597709 Methods for simultaneous amplification of target loci
US Patent 10597723 Methods for simultaneous amplification of target loci
US Patent 10655180 Methods for simultaneous amplification of target loci
US Patent 10711309 System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11479812
Patent Primary Examiner
Catherine S Hibbert
CPC Code
G16B 20/00
Y02A 90/10
G16H 10/40
C12Q 2600/156
C12Q 1/6858
C12Q 1/6869
C12Q 1/6886
C12Q 2539/10
C12Q 2600/106
Find more entities like US Patent 11479812 Methods and compositions for determining ploidy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE